These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 25691421)
1. Partial MEF2C deletion in a Cypriot patient with severe intellectual disability and a jugular fossa malformation: review of the literature. Tanteles GA; Alexandrou A; Evangelidou P; Gavatha M; Anastasiadou V; Sismani C Am J Med Genet A; 2015 Mar; 167A(3):664-9. PubMed ID: 25691421 [TBL] [Abstract][Full Text] [Related]
2. Microdeletion 5q14.3 and anomalies of brain development. Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879 [TBL] [Abstract][Full Text] [Related]
3. MEF2C deletions and mutations versus duplications: a clinical comparison. Novara F; Rizzo A; Bedini G; Girgenti V; Esposito S; Pantaleoni C; Ciccone R; Sciacca FL; Achille V; Della Mina E; Gana S; Zuffardi O; Estienne M Eur J Med Genet; 2013 May; 56(5):260-5. PubMed ID: 23402836 [TBL] [Abstract][Full Text] [Related]
4. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C. Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus. Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106 [TBL] [Abstract][Full Text] [Related]
6. Interstitial 1q23.3q24.1 deletion in a patient with renal malformation, congenital heart disease, and mild intellectual disability. Mackenroth L; Hackmann K; Klink B; Weber JS; Mayer B; Schröck E; Tzschach A Am J Med Genet A; 2016 Sep; 170(9):2394-9. PubMed ID: 27255444 [TBL] [Abstract][Full Text] [Related]
7. MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review. Rocha H; Sampaio M; Rocha R; Fernandes S; Leão M Eur J Med Genet; 2016 Sep; 59(9):478-82. PubMed ID: 27255693 [TBL] [Abstract][Full Text] [Related]
8. Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype. Cesaretti C; Spaccini L; Righini A; Parazzini C; Conte G; Crosti F; Redaelli S; Bulfamante G; Avagliano L; Rustico M Am J Med Genet A; 2016 May; 170A(5):1352-7. PubMed ID: 26864752 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive investigation of the phenotype of MEF2C-related disorders in human patients: A systematic review. Cooley Coleman JA; Sarasua SM; Boccuto L; Moore HW; Skinner SA; DeLuca JM Am J Med Genet A; 2021 Dec; 185(12):3884-3894. PubMed ID: 34184825 [TBL] [Abstract][Full Text] [Related]
10. Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndrome. Khalifa M; Stein J; Grau L; Nelson V; Meck J; Aradhya S; Duby J Am J Med Genet A; 2013 Apr; 161A(4):835-40. PubMed ID: 23494856 [TBL] [Abstract][Full Text] [Related]
11. Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature? Fernández Hernández L; Alcántara Ortigoza MA; Ramos Angeles SE; González-Del Angel A Cytogenet Genome Res; 2021; 161(12):556-563. PubMed ID: 35021179 [TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11. Goldenberg A; Riccardi F; Tessier A; Pfundt R; Busa T; Cacciagli P; Capri Y; Coutton C; Delahaye-Duriez A; Frebourg T; Gatinois V; Guerrot AM; Genevieve D; Lecoquierre F; Jacquette A; Khau Van Kien P; Leheup B; Marlin S; Verloes A; Michaud V; Nadeau G; Mignot C; Parent P; Rossi M; Toutain A; Schaefer E; Thauvin-Robinet C; Van Maldergem L; Thevenon J; Satre V; Perrin L; Vincent-Delorme C; Sorlin A; Missirian C; Villard L; Mancini J; Saugier-Veber P; Philip N Am J Med Genet A; 2016 Nov; 170(11):2847-2859. PubMed ID: 27605097 [TBL] [Abstract][Full Text] [Related]
13. Phenotype-genotype correlation of a patient with a "balanced" translocation 9;15 and cryptic 9q34 duplication and 15q21q25 deletion. Papadopoulou E; Sismani C; Christodoulou C; Ioannides M; Kalmanti M; Patsalis P Am J Med Genet A; 2010 Jun; 152A(6):1515-22. PubMed ID: 20503328 [TBL] [Abstract][Full Text] [Related]
14. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum. Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023 [TBL] [Abstract][Full Text] [Related]
15. Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report. Yauy K; Schneider A; Ng BL; Gaillard JB; Sati S; Coubes C; Wells C; Tournaire M; Guignard T; Bouret P; Geneviève D; Puechberty J; Pellestor F; Gatinois V BMC Med Genomics; 2019 Aug; 12(1):116. PubMed ID: 31375103 [TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic characterization and genotype/phenotype analysis in a patient with a de novo 8p23.2p23.3 deletion/12p13.31p13.33 duplication. Margari L; Di Cosola ML; Buttiglione M; Pansini A; Buonadonna AL; Craig F; Cariola F; Petruzzelli MG; Gentile M Am J Med Genet A; 2012 Jul; 158A(7):1713-8. PubMed ID: 22639464 [TBL] [Abstract][Full Text] [Related]
17. De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature. Becker K; Di Donato N; Holder-Espinasse M; Andrieux J; Cuisset JM; Vallée L; Plessis G; Jean N; Delobel B; Thuresson AC; Annerén G; Ravn K; Tümer Z; Tinschert S; Schrock E; Jønch AE; Hackmann K Eur J Med Genet; 2012; 55(8-9):490-7. PubMed ID: 22561202 [TBL] [Abstract][Full Text] [Related]
18. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390 [TBL] [Abstract][Full Text] [Related]
19. Jugular pit associated with 5q14.3 deletion incorporating the MEF2C locus: a recurrent clinical finding. Al-Shehhi M; Betts D; Mc Ardle L; Donoghue V; Reardon W Clin Dysmorphol; 2016 Jan; 25(1):23-6. PubMed ID: 26426104 [No Abstract] [Full Text] [Related]
20. Clinical characteristics in patients with interstitial deletions of chromosome region 12q21-q22 and identification of a critical region associated with keratosis pilaris. Al-Maawali A; Marshall CR; Scherer SW; Dupuis L; Mendoza-Londono R; Stavropoulos DJ Am J Med Genet A; 2014 Mar; 164A(3):796-800. PubMed ID: 24375972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]